Cascader

Diagnostics using oculomics.

Enabling the early detection of systemic disease through the analysis of retinal scans and AI interpretation.

Their mission is to use AI to enable safe, evidence-based decisions in high-volume, high-risk eye conditions, preventing avoidable sight loss.

The Cascader journey so far:

2025: spinout officially launched by Moorfields Eye Hospital, UCL IoO, and Topcon Healthcare.

Team

Professor Pearse Keane

Founder and Chief Medical Officer

Professor Keane is an expert in eye-related artificial intelligence and Oculomics. He helped create RETFound, the first major model for eye care, and has shaped the area of Oculomics.

Dr. Mark Fisher

Associate Director

Global Business School for Health

Dr Fisher is responsible for the BioPharm patent portfolio and strategic business support. He brings more than 30 years' experience in life sciences and healthcare licensing and company development.